Saturday, May 7, 2022 12:30 PM – 2:30 PM Oregon Ballroom 204
Co-Chairs:
Andrew D. Weinberg, PhD - Earle A. Chiles Research Institute
Paul F. Robbins, PhD - NCI, NIH
Schedule:
Identifying tumor-reactive CD8+ TIL in patients with solid malignancies: clinical implications
Andrew D. Weinberg, PhD - Earle A. Chiles Research Institute
Clonal dynamics of tumor-infiltrating T cells in response to checkpoint blockade immunotherapy
Kathryn E. Yost, PhD - Whitehead Institute
Harnessing the personalized antitumor T cell response to treat cancer
Alena Gros, PhD - Vall d'Hebron Inst. of Oncology, Spain
Isolating and characterizing neo-antigen reactive T cells in patients with solid tumors
Paul F. Robbins, PhD - NCI, NIH